These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10704714)
1. Synthesis and construction of a novel multiple peptide conjugate system: strategy for a subunit vaccine design. Boykins RA; Joshi M; Syin C; Dhawan S; Nakhasi H Peptides; 2000 Jan; 21(1):9-17. PubMed ID: 10704714 [TBL] [Abstract][Full Text] [Related]
2. Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection. Devadas K; Boykins RA; Hewlett IK; Wood OL; Clouse KA; Yamada KM; Dhawan S Peptides; 2007 Mar; 28(3):496-504. PubMed ID: 17188401 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of a diepitope multiple antigen peptide containing sequences from two malaria antigens using Fmoc chemistry. Ahlborg N J Immunol Methods; 1995 Feb; 179(2):269-75. PubMed ID: 7533196 [TBL] [Abstract][Full Text] [Related]
4. Chemical cross-linking of the human immunodeficiency virus type 1 Tat protein to synthetic models of the RNA recognition sequence TAR containing site-specific trisubstituted pyrophosphate analogues. Naryshkin NA; Farrow MA; Ivanovskaya MG; Oretskaya TS; Shabarova ZA; Gait MJ Biochemistry; 1997 Mar; 36(12):3496-505. PubMed ID: 9131999 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of a novel lipid-peptide conjugate for functionalized liposome. Yagi N; Yano Y; Hatanaka K; Yokoyama Y; Okuno H Bioorg Med Chem Lett; 2007 May; 17(9):2590-3. PubMed ID: 17317168 [TBL] [Abstract][Full Text] [Related]
6. 6746 SERA peptide analogues immunogenicity and protective efficacy against malaria is associated with short alpha helix formation: malaria protection associated with peptides alpha helix shortening. Alba MP; Salazar LM; Puentes A; Pinto M; Torres E; Patarroyo ME Peptides; 2003 Jul; 24(7):999-1006. PubMed ID: 14499278 [TBL] [Abstract][Full Text] [Related]
7. Immunization with a novel HIV-1-Tat multiple-peptide conjugate induces effective immune response in mice. Boykins RA; Ardans JA; Wahl LM; Lal RB; Yamada KM; Dhawan S Peptides; 2000 Dec; 21(12):1839-47. PubMed ID: 11150644 [TBL] [Abstract][Full Text] [Related]
8. A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity. Defoort JP; Nardelli B; Huang W; Tam JP Int J Pept Protein Res; 1992; 40(3-4):214-21. PubMed ID: 1478779 [TBL] [Abstract][Full Text] [Related]
10. Chemically-assisted fragmentation combined with multi-dimensional liquid chromatography and matrix-assisted laser desorption/ionization post source decay, matrix-assisted laser desorption/ionization tandem time-of flight or matrix-assisted laser desorption/ionization tandem mass spectrometry for improved sequencing of tryptic peptides. Flensburg J; Tangen A; Prieto M; Hellman U; Wadensten H Eur J Mass Spectrom (Chichester); 2005; 11(2):169-79. PubMed ID: 16046801 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of an amino acid analogue to incorporate p-aminobenzyl-EDTA in peptides. Song AI; Rana TM Bioconjug Chem; 1997; 8(2):249-52. PubMed ID: 9095368 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC). Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348 [TBL] [Abstract][Full Text] [Related]
13. Multiple antigen peptides (MAPs) as candidate vaccines against malaria. Pessi A; Bianchi E; Chiappinelli L; Bonelli F; Tougne C; Lambert PH; Del Giudice G Parassitologia; 1991 Apr; 33(1):79-84. PubMed ID: 1668679 [TBL] [Abstract][Full Text] [Related]
14. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization. Ramakrishna L; Anand KK; Mohankumar KM; Ranga U J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713 [TBL] [Abstract][Full Text] [Related]
15. Construction of a synthetic immunogen: use of the natural immunomodulator polytuftsin in malaria vaccines against RESA antigen of Plasmodium falciparum. Pawan K; Ivanov BB; Kabilan L; Rao DN Vaccine; 1994 Jul; 12(9):819-24. PubMed ID: 7526572 [TBL] [Abstract][Full Text] [Related]
16. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease. Jayasena SD; Johnston BH Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648 [TBL] [Abstract][Full Text] [Related]
17. Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant DeltaV2 Env. Ensoli B; Cafaro A; Caputo A; Fiorelli V; Ensoli F; Gavioli R; Ferrantelli F; Cara A; Titti F; Magnani M Microbes Infect; 2005 Nov; 7(14):1392-9. PubMed ID: 16243561 [TBL] [Abstract][Full Text] [Related]
18. Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Tréhin R; Nielsen HM; Jahnke HG; Krauss U; Beck-Sickinger AG; Merkle HP Biochem J; 2004 Sep; 382(Pt 3):945-56. PubMed ID: 15193145 [TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies. Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663 [TBL] [Abstract][Full Text] [Related]
20. Site-specific cross-linking of amino acids in the basic region of human immunodeficiency virus type 1 Tat peptide to chemically modified TAR RNA duplexes. Farrow MA; Aboul-ela F; Owen D; Karpeisky A; Beigelman L; Gait MJ Biochemistry; 1998 Mar; 37(9):3096-108. PubMed ID: 9485463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]